Anavex Life Sciences
AVXL
#7563
Rank
ยฃ0.29 B
Marketcap
ยฃ3.30
Share price
-1.12%
Change (1 day)
-44.55%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2025 (TTM): -ยฃ39.64 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -ยฃ38.7 Million a decrease over its 2023 earnings that were of -ยฃ33.72 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ39.64 Million2.41%
2024 -ยฃ38.7 Million14.77%
2023 -ยฃ33.72 Million-17.49%
2022 -ยฃ40.87 Million22.96%
2021 -ยฃ33.24 Million35.36%
2020 -ยฃ24.56 Million12.65%
2019 -ยฃ21.8 Million29.09%
2018 -ยฃ16.89 Million36.33%
2017 -ยฃ12.39 Million17.11%
2016 -ยฃ10.58 Million20.91%
2015 -ยฃ8.75 Million-6.29%
2014 -ยฃ9.34 Million337.28%
2013 -ยฃ2.14 Million
2008 -ยฃ3.95 Million106.01%
2007 -ยฃ1.92 Million8848.98%
2006 -ยฃ0.03 Million-79.99%
2005 -ยฃ0.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
ยฃ50.13 M-228.33%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-ยฃ4.97 Million-87.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
ยฃ49.22 M-225.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-ยฃ12.99 Million-66.78%๐Ÿ‡บ๐Ÿ‡ธ USA